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The performances of the gelatin particle agglutination test (GPAT) and enzyme-linked immunosorbent assay
(ELISA) for the diagnosis of strongyloidiasis with reference to the results of the agar plate culture technique
(APCT) were evaluated with samples from 459 individuals from communities in northeast Thailand where
strongyloidiasis is endemic. The prevalence of strongyloidiasis in five sample groups determined by GPAT
varied between 29.3 and 61.5% (mean, 38.8%). ELISA and APCT, employed concurrently, gave lower prevalence
rates of 27.5% (range, 21.6 to 42.1%) and 22.7% (range, 12.7 to 53.8%), respectively. By using APCT as the
standard method, the sensitivity of GPAT was generally higher than that of ELISA (81 versus 73%). The
specificity of GPAT was slightly lower than that of ELISA (74 versus 86%). The resulting GPAT titers exhibited
positive linear relationships with the ELISA values (optical density at 490 nm) (P < 0.05), which suggests that
the GPAT titer also reflects the levels of specific antibody comparable to those reflected by the ELISA values.
Based on the relative ease and simplicity of use of the technique as well as the acceptable rates of sensitivity
and specificity of the test, GPAT is more practical for screening for strongyloidiasis than the conventional
ELISA.
Strongyloides stercoralis is an intestinal nematode with a
worldwide distribution, especially in tropical and subtropical
areas (9). It has the unique ability to induce hyperinfection and
disseminated infection, particularly in individuals immunosup-
pressed because of long-term or high-dose corticosteroid che-
motherapeutic treatments. To avoid such a condition, employ-
ment of a sensitive and specific means of diagnosis and timely
curative anthelmintic treatment is necessary. Conventional fe-
cal examination methods are often unreliable for demonstra-
tion of the characteristic S. stercoralis larvae due to the low
intensity of the infection and the low fecundity of the parasite
(20). Improved parasitological methods, particularly the agar
plate culture technique (APCT), considerably increased the
detection rate, and it is currently regarded as the most sensitive
fecal examination technique (1, 15). However, coprodiagnosis
has drawbacks, and repeat fecal examinations three or more
times is required to achieve a reliable diagnosis of the infection
(23). In this regard, serological diagnosis, particularly the en-
zyme-linked immunosorbent assay (ELISA), has considerable
advantages over parasitological methods, since only a single
serum sample is required; and hence, it has been widely used
as the test of choice for the diagnosis of strongyloidiasis (10,
21). However, ELISA must be performed in a well-equipped
laboratory with specific equipment and trained technicians.
Alternatively, the gelatin particle agglutination test (GPAT) is
simpler to perform, as it requires no special equipment and it
is less labor-intensive and much cheaper than ELISA. It has
been widely used as a tool for the screening of several infec-
tious diseases, such as leprosy (12), Mycobacterum leprae in-
fection (7), human immunodeficiency virus infection (30), as
well as strongyloidiasis (25).
In our recent study (28), we demonstrated by APCT that the
prevalence of strongyloidiasis in rural communities in north-
east Thailand is high and surpasses that of Opisthorchis viverrini
infection, which has predominated in this area for decades. In
that study, application of ELISA as a supplementary method of
serodiagnosis revealed as many as 46% of additional positive
cases. Therefore, serodiagnosis has become an important
method of choice for the diagnosis of strongyloidiasis in areas
of endemicity.
The aim of the present work was to assess the performance
and effectiveness of GPAT and ELISA for the diagnosis of
human strongyloidiasis in northeast Thailand by using APCT
as the reference method.
MATERIALS AND METHODS
Sample population. The sample population included villagers from three rural
communities from the previous study (28), namely, Haui Ma Tho (HMT) in
Kalasin Province and Nong Kae (NEK) and Chonnabot (KT) in Khon Kaen
Province, and two additional communities, namely, Ban Moung (BM) and Nam
Pong (NP) in Khon Kaen Province; all are in northeast Thailand. The total
sample of 459 individuals, from whom paired fecal and serum specimens were
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available, were recruited for this study. The clinical samples were collected in the
field and kept in an insulated icebox for transport to the laboratory.
Serum samples. Three groups of serum samples were analyzed in this study.
Group I consisted of 459 serum samples from the populations in the communi-
ties in northeast Thailand described above. Group II consisted of serum samples
from people with one other parasite infection but in whom S. stercoralis was not
demonstrated by APCT. This group included 14 individuals infected with O.
viverrini, 28 individuals infected with Clonorchis sinensis, 23 individuals infected
with echinostomes, 16 individuals infected with minute intestinal flukes (Phan-
eropsolus and Prostodendrium spp.), 12 individuals infected with Taenia, 34 in-
dividuals with hookworms, 1 individual infected with Angiostrongylus cantonensis,
and 10 individuals infected with Giardia intestinalis. These serum samples were
used to identify the cross-reactivity of GPAT and ELISA between S. stercoralis
and other parasites, and no subjects with multiple infections were recruited into
this group. Group III consisted of 50 serum samples from noninfected, healthy
controls from northeast Thailand used to establish the cutoff values for serolog-
ical diagnosis by both GPAT and ELISA.
Fecal examination methods. The presence of S. stercoralis in the fecal samples
was determined by the agar plate culture technique with approximately 4 g of
feces, as described by Koga et al. (15). The other 2 g of fecal specimen was
simultaneously processed for the modified formalin-ethyl acetate concentration
technique (6) to search for concurrent parasite infections. Positive results by
either method were taken as positive for strongyloidiasis and were taken as a
“gold standard” diagnosis.
Antigen preparation. The method for antigen preparation of the crude so-
matic extract of the third-stage filariform larvae (L3) of S. stercoralis was per-
formed as described previously (28). In brief, the larvae were originally obtained
from cultures of feces from an infected patient by the filter paper culture
technique of Harada and Mori (11). After 4 to 6 days of culture of S. stercoralis-
positive feces at room temperature, the larvae were harvested and washed sev-
eral times in normal saline. When the amount of larvae was adequate, usually 2
to 3 ml, the larval pellet was suspended in phosphate-buffered saline (PBS)
containing protease inhibitors and was disrupted by sonication (4). The homog-
enate was left at 4°C overnight and centrifuged at 17,266  g for 30 min at 4°C.
The supernatant was separated and used as the antigen, and the protein con-
centration was measured by the method of Lowry et al. (18) and kept at 20°C.
The antigen was used for serodiagnosis by GPAT and ELISA.
ELISA. The indirect (optical density [OD]-based) ELISA was performed as
described previously (28). The protocol was similar to those described by other
investigators (4, 29). The microplates (Maxisorb; Nunc, Roskilde, Denmark)
were coated with 100 l of 2 g/ml of the antigen in carbonate buffer (pH 9.6)
at 4°C overnight. After removal of unbound antigen by three 3-min washes with
PBS containing 0.05% Tween (PBST), 200 l of 5% skim milk in PBS was added
to each well and the plate was kept at room temperature for 1 h. The wells were
washed three times for 3 min each time with PBS, 100 l of the serum samples
(dilution, 1:1,500 in 2% skim milk in PBST, in duplicate) was added to the plate,
and the plate was incubated for 1 h at 37°C. After the plate was washed three
times, 100 l of horseradish peroxidase anti-human immunoglobulin G (IgG;
Zymed) in 2% skim milk in PBST (dilution, 1:5,000) was added to each well, and
the plate was incubated at 37°C for 1 h. After the plate was washed, 100 l of
substrate solution (0.4 mg/ml of o-phenylenediamine, 0.001% H2O2 in citrate
buffer, pH 5.0) was added to each well. After 15 min at 37°C, the reaction was
stopped with 100 l of 4 N H2SO4. The optical density of the reaction was
measured at 490 nm with a microplate reader (Dynatech MR 5000). The ELISA
result was judged to be positive when the OD was greater than the cutoff OD of
0.26. The cutoff OD was calculated from the mean OD for 50 negative control
cases plus 3 standard deviations.
Gelatin particle agglutination assay. GPAT was performed as described by
Sato et al. (25). The unsensitized gelatin particles (Fujirebio Inc., Japan) were
suspended in PBS (pH 6.4), washed four times in PBS, and adjusted to a
concentration of 3%. Equal volumes of 0.01 mg/ml of tannic acid in PBS were
added to the gelatin suspension and kept in ice for 15 min and mixed every 5 min.
Then, the gelatins were washed three times with cold PBS and readjusted to the
original concentration (3%). Based on the preliminary experiment, an equal
volume of 60 g/ml S. stercoralis antigen was then mixed with the gelatin sus-
pension and the antigen absorption reaction was allowed to take place for 15 min
in a 37°C water bath with continuous mixing. Any excess antigen was removed by
washing four times with 0.2% bovine serum albumin (BSA) in PBS, and the final
concentration of the gelatin suspension was adjusted to 1% and kept at 4°C until
required for testing. The unsensitized gelatin particles for the control experi-
ments were also prepared in the same manner, except that normal saline was
used instead of the antigen. GPAT was performed in a U-bottom plate with a
twofold dilution of 25 l of the serum samples with 0.2% BSA in PBS and 25 l
of the 1% gelatin particle suspension. After gentle mixing of the contents of the
plate, the plate was left at room temperature for 2 h prior to interpretation of the
test result. The agglutination pattern was considered positive when the smooth
mat of particles spread uniformly and covered the entire bottom of the well, and
the edge of the mat was sometimes folded. If the gelatin particles were concen-
trated at the center of the well, it was interpreted as a negative reaction. If any
equivocal pattern appeared, the samples were retested and the results were read
by two individuals for final interpretation of the results. The highest antibody
dilution that gave a positive agglutination reaction was taken as the antibody
titer. The cutoff value for a positive titer for GPAT was 32, and this was obtained
from the tests done with 50 negative control serum samples. For quality control,
in each run of the GPAT, the titer of the positive control used for the entire
experiment should be 1:1,024 1 doubling dilution. In addition, wells with
unsensitized particles in the presence of the test serum and the sensitized particle
in the presence of PBS should give negative reactions.
This study was reviewed and approved by the Ethics Committee on Human
Research, Faculty of Medicine, Khon Kaen University.
Statistical analyses. The OD and antibody titers were not normally distrib-
uted, and thus, the data were log transformed. Kendall’s tau correlation coeffi-
cient was used to assess the relationship between the OD values and the antibody
titers. Statistical tests were performed with the SPSS v.10 statistical package.
RESULTS
The prevalences of strongyloidiasis in rural northeast Thai
communities measured by APCT, ELISA, and GPAT are pre-
sented in Table 1. GPAT gave a consistently higher rate of
positivity in each community than the other two techniques.
The prevalence in each community as determined by GPAT
ranged from 4 to 27% and from 8 to 28% higher than those
determined by ELISA and APCT, respectively. The overall
prevalence by GPAT was 38.7%, while that by ELISA was
27.5%; and the lowest was 22.7%, as determined by APCT. In
general, ELISA yielded higher prevalence rates than APCT in
most groups of subjects except in one community (KT), where
the rate of positivity by APCT was higher than that by ELISA.
The sensitivity and specificity of GPAT and ELISA with
reference to the results of APCT as the gold standard among
subjects from the different communities are listed in Table 2.
The sensitivities of GPAT were greater than those of ELISA in
all the communities studied; and the overall sensitivity was
81% by GPAT, while that by ELISA was 73%. In contrast, the
overall specificity of GPAT (74%) was slightly lower than that
of ELISA (86%). The positive predictive value of ELISA was
greater than that of GPAT, while the negative predictive val-
ues were similar between the two methods of serodiagnosis.
Statistical analyses of the relationship between the antibody
titer by GPAT and the ELISA values (OD at 490 nm [OD490])
for each community revealed a significant positive correlation
(Kendall’s tau correlation coefficient  0.44 to 0.63; P  0.01;
TABLE 1. Comparison of rates of positivity for S. stercoralis among
populations sampled in northeast Thailand as determined by APCT,
ELISA, GPAT
Village Total no. ofpatients
No. (%) positive by:
APCT ELISA GPAT
HMT 57 16 (28.1) 24 (42.1) 32 (56.1)
BM 182 44 (24.1) 45 (24.7) 69 (37.9)
KT 26 14 (53.8) 9 (34.6) 16 (61.5)
NP 157 20 (12.7) 40 (25.4) 46 (29.3)
NEK 37 10 (27.0) 8 (21.6) 15 (40.5)
Total 459 104 (22.7) 126 (27.5) 178 (38.8)
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R  0.78 to 0.88). The relationship of the overall data for the
antibody titers by GPAT and the ELISA values was also sig-
nificant (P  0.01) (Fig. 1). A highly variable relationship was
observed at an antibody titer 256, but a more proportionate
correlation occurred at titers 256.
To determine the specificity of the test, sera from subjects
infected by other parasites common in the area and the avail-
able sera were analyzed for cross-reactivity in the GPAT and
ELISA. Cross-reactions identified by GPAT and ELISA were
found with the sera of individuals harboring O. viverrini and
hookworms (Table 3). No cross-reaction was observed for sera
from individuals infected with Taenia spp., echinostomes,
minute intestinal fluke, Clonorchis sinensis, Angiostrongylus
cantonensis, and Giardia intestinalis.
Within the group of individuals APCT negative for S. ster-
coralis (n  355), 94 of them (26.5%) were GPAT positive. A
comparison of the rates of concurrent parasitic infections
among the GPAT-negative and GPAT-positive groups is
shown in Table 4. The rates of infection with the two parasites
shown to result in cross-reactions between GPAT and ELISA
(Table 3), namely, O. viverrini and hookworm, were compara-
ble. The other parasites, i.e., minute intestinal fluke, echinos-
tomes, Taenia, and G. intestinalis, occurred more frequently in
the GPAT-positive individuals than in their GPAT-negative
counterparts. The total rate of infection in GPAT-positive
individuals was also higher than that in the GPAT-negative
group.
DISCUSSION
In our study, GPAT for the diagnosis of strongyloidiasis in
communities in northeast Thailand where the disease is en-
demic was established, and its efficacy was compared with that
of ELISA by using coprodiagnosis as the reference method. In
general, GPAT gave higher rates of positivity than ELISA and
the parasitological method, APCT. It is interesting that all of
the proven cases of strongyloidiasis based on the results of
APCT were positive by GPAT, and the sensitivity of GPAT
FIG. 1. Relationship between antibody titer by GPAT and ELISA
value (OD490) for samples from 459 individuals in five localities in
northeast Thailand. The data shown are the observed values, and the
solid line is the linear regression line with a slope of 0.241 and a y-axis
intercept of 0.45 (t  25.7; P  0.001; R  0.77).
TABLE 2. Sensitivities and specificities of ELISA and GPAT for
diagnosis of S. stercoralis infection in the population sampled in
northeast Thailanda
Diagnostic
method Village
Sensitivity
(%)
Specificity
(%)
Positive
predictive
value (%)
Negative
predictive
value (%)
ELISA HMT 75 71 50 88
BM 75 91 73 92
KT 43 75 67 53
NP 85 83 43 97
NEK 80 100 100 93
Overall 73 86 60 92
GPAT HMT 81 81 41 88
BM 75 75 41 88
KT 79 79 69 70
NP 90 90 39 98
NEK 90 90 60 95
Overall 81 81 47 93
a The results of APCT, performed with samples from the same individuals,
were used as the reference. The analysis was based on a total sample size of 459
individuals.
TABLE 3. Comparison of cross-reactions of S. stercoralis antigen
with sera from patients with other parasitic infections determined by
GPAT and ELISAa
Parasite Total no. ofpatients
No. (%) positive
GPAT ELISA
Opisthorchis viverrini 14 1 (7.1) 1 (7.1)
Clonorchis sinensis 28 0 (0) 0 (0)
Echinostomes 23 0 (0) 0 (0)
Minute intestinal flukes 16 0 (0) 0 (0)
Taenia spp. 12 0 (0) 0 (0)
Hookworms 34 2 (5.7) 1 (2.8)
Angiostrongylus
cantonensis
1 0 (0) 0 (0)
Giardia intestinalis 10 0 (0) 0 (0)
Total 138 3 (2.2) 2 (1.4)
a The GPAT result was positive when the titer was32. The ELISA result was
positive when the OD490 was 0.26.
TABLE 4. Rates of parasitic infections among subjects who were
negative for strongyloidiasis by APCTa
Parasite
No. (%) of subjects with the following
GPAT result:
Negative (n  261) Positive (n  94)
O. viverrini 22 (8.42) 8 (8.51)
Hookworms 48 (18.39) 16 (17.02)
Minute intestinal fluke 13 (4.98) 14 (14.89)
Echinostomes 1 (0.38) 4 (4.26)
Taenia 1 (0.38) 2 (2.12)
Hymenolepis diminuta 1 (0.38) 0 (0)
Giardia intestinalis 16 (6.13) 10 (10.63)
Total 102 (39.08) 54 (57.4)
a Samples from 355 subjects were tested. These subjects were classified as
serologically negative and positive by GPAT. Coprodiagnosis for the concurrent
parasitic infections was determined by formalin-ethyl acetate concentration tech-
nique (FECT), except for hookworm, for which the results of both APCT and
FECT were combined.
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was comparable to or better than that of conventional ELISA
in terms of both the rate of positivity and the sensitivity. How-
ever, a slightly lower specificity was obtained compared with
that of ELISA, and the rates of cross-reactions with hook-
worms by GPAT were also higher than those by ELISA. The
rates of cross-reactivity with O. viverrini and S. stercoralis were
comparable between ELISA and GPAT. In this study, the
activities of the sensitized gelatin particles were relatively sta-
ble when they were kept at 4°C for at least 3 months. With
further study on the method of long-term preservation and the
shelf life of the sensitized gelatin particles, GPAT could be a
promising candidate for mass screening for strongyloidiasis in
areas of endemicity. Such screening would help detect patients
with unidentified chronic infections and high-risk individuals
for a more definite diagnosis, thus reducing costs and the time
needed for repeat stool examinations for the diagnosis of
strongyloidiasis.
The high variability in the prevalence of S. stercoralis en-
countered among different communities in this study was not
unexpected, because a recent study in northeast Thailand (n 
1,233) also found a similar pattern of infection (13), with the
prevalences in different provinces ranging from 13.3 to 61%.
From that study (13), the prevalence of S. stercoralis infection
in Khon Kaen was 16.5%, whereas it ranged from 12.7 to
53.8% in four communities (BM, KT, NP, and NEK) in the
same province. Likewise, the prevalence in Kalasin Province
was 61%, whereas it was 28.1% in HMT, which is a community
in Kalasin Province. Therefore, the background prevalence of
S. stercoralis in each province may not be the sole factor con-
tributing to the differences in prevalence observed in the com-
munities evaluated in this study.
The observed cross-reaction of GPAT with the sera from
patients infected with O. viverrini and hookworms was not
entirely unexpected, since several species of parasites coexist in
the area and it is uncommon to find individuals infected with a
single species of parasite. The observed cross-reactivity was
therefore probably associated with multiple infections or pre-
vious exposure to the helminths and was partially due to the
nature of the crude somatic extract of the antigen of S. sterco-
ralis used in GPAT and ELISA. A similar cross-reactivity of
GPAT to hookworms and the agents responsible for an-
giostrongyliasis, sparganosis, and cysticercosis was reported
previously (25). The sera of individuals with occult filariasis
and schistosomiasis also showed consistent cross-reactions by
the indirect hemagglutination test (8). The use of the partially
purified third-stage larval antigen for ELISA has slightly im-
proved the efficiency of the ELISA over that obtained with
crude or unpurified antigen fractions (19). Recently, in the
immediate hypersensitivity skin test for strongyloidiasis with
crude and excretory-secretory antigen, cross-reaction with fi-
laria-positive sera was also encountered (22). These cross-
reactions may be minimized by using a more complicated
Western blot analysis, whose sensitivity and specificity are
greatly increased (5, 17). It appears, therefore, that the iden-
tification of a specific antigen(s) is the precondition for elim-
ination of these cross-reactions with other helminths (27).
Additionally, in the case of infection with multiple parasites,
preincubation of the sera with certain parasite antigens to
reduce the cross-reacting antibodies improved the specificity of
the serological test by ELISA (4). Those authors found that for
patients with hookworm infections, when the sera were prein-
cubated with an extract of Ascaris lumbricoides, the cross-re-
acting IgG could be effectively reduced. It remains to be de-
termined whether this approach will similarly improve the
specificity of GPAT.
In our study, a single fecal sample from each subject was
collected for examination, and thus, GPAT gave the correct
test results not only for all of the fecal sample-positive indi-
viduals but also for the fecal-negative individuals. Although
triple stool examinations are recommended (23), it would be
interesting to investigate how many more fecal sample-positive
cases could be retrieved by repeated fecal sampling for analysis
by APCT (among the fecal sample-negative individuals). Al-
though concurrent parasitic infections were commonly ob-
served in this study, two major cross-reactive parasites, O.
viverini and hookworm, occurred in similar percentages of
GAPT-positive and -negative individuals. It is unlikely that
they may cause false-positive test results. However, the influ-
ence of higher rates of infection with other parasites for the
GPAT-positive group than the GPAT-negative group upon the
false-positive test result is difficult to rule out. More study is
needed to resolve this issue. By contrast, in the case of ELISA,
the rates of false-negative test results for patients with proven
strongyloidiasis ranged from 16 to 20% (2, 3, 24). Such findings
indicate that the wide spectrum of host immune responses
against S. stercoralis infection influences the outcome of the
serodiagnostic assays. This difference in the individual re-
sponse to infection may affect not only serodiagnosis but also
the effectiveness of drug treatment. For example, elevated S.
stercoralis-specific IgG4 has been found to be associated with
albendazole resistance (26) or ivermectin resistance (16).
The finding that the antibody titer by GPAT positively cor-
related with the OD values obtained by ELISA suggested that
GPAT provided not only a qualitative measurement but also a
semiquantitative measurement. Whether the rate of change in
these values after chemotherapy will be proportional and
which measurement is a better marker of curative treatment is
not known. ELISA was employed to evaluate the outcome of
treatment (14), but no investigation with GPAT has been done.
In conclusion, the results of our study demonstrated that
GPAT is more sensitive than ELISA for the serodiagnosis of
strongyloidiasis. The results also demonstrated that GPAT is
superior to ELISA. In particular, GPAT is easy to perform and
there is no need for specialized equipment. In addition, the
gelatin particles have many advantages as an antigen carrier,
e.g., in handling and reading of the resulting pattern. The test
was considered to be more convenient than the conventional
ELISA for mass screening for strongyloidiasis in an area of
endemicity and may be applied as a routine laboratory test to
rule out strongyloidiasis in immunosuppressed patients and
patients with malignancies.
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